Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 17 (2) , 169-175
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic OriginInternational Journal of Hepatology, 2012
- Prognostic Factors and Characteristics of Pancreatic Neuroendocrine Tumors: Single Center ExperienceYonsei Medical Journal, 2012
- Surgical Treatment of Sporadic Pancreatic Neuroendocrine Tumors: A State of the Art ReviewThe Scientific World Journal, 2012
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Gut, 2011
- Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine TumorsJournal of Hematology & Oncology, 2011
- Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine TumorsArchives of Surgery, 2011
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patientsLaboratory Investigation, 2010
- A simplified prognostic system for resected pancreatic neuroendocrine neoplasmsHPB, 2009
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survivalAnnals of Oncology, 2008
- An Aggressive Surgical Approach Leads to Long-term Survival in Patients With Pancreatic Endocrine TumorsAnnals of Surgery, 2006